Raritan Pharmaceuticals 401(k) Review & Grade
Raritan Pharmaceuticals 401(k) Profit Sharing Plan & Trust
East Brunswick, NJManufacturing526 active participantsPlan year 2024
Estimate from the plan's Form 5500 filing · How we grade
$551Employer $ per active participant
$1,374Employee $ saved per active participant
0.48%Direct admin cost, % of plan assets
$7.2MNet plan assets, end of year
–Average balance per account (account count looks misreported)
Score breakdown
- Employer generosity3.9 / 508th percentile for employer $ per participant
- Low cost6.1 / 2524th percentile for low admin cost vs. same-size plans
- Employee saving0.9 / 156th percentile for employee $ per participant
- Plan features3 / 10Default investment
Total score14 / 100 · Grade F
This plan vs. peers
Peers: Manufacturing plans with 500–2,499 active participants (2,376 plans).
| Measure | Percentile |
|---|---|
| Employer $ per participant | 8th |
| Lower admin cost | 24th |
| Employee saving | 6th |
| Peers that auto-enroll | 59% |
Get the monthly 401(k) report card
The best and worst plans, new grades as filings post. One email a month, no spam.
Red flags from the filing
No red flags were reported on this filing's compliance questions.
What to do if you're in this plan
- Raritan Pharmaceuticals put in about $551 per active participant, below the typical peer ($2,320). Any match is still an instant return, so contribute enough to get all of it.
- The filing shows total dollars, not the match formula. Ask HR for the Summary Plan Description so you know the exact match and vesting schedule.
- Direct plan expenses (0.48% of assets) are well above similar-size plans (0.23%). Check your annual fee disclosure, choose low-cost index funds if you can, and think about whether savings beyond the match belong in an IRA.
- Changing jobs? You can usually leave the money in the plan, move it to your new employer's plan, or roll it into an IRA. Don't cash out: you'd owe taxes and possibly a 10% penalty.
The raw numbers from the filing
| Employer contributions | $289,821 |
| Participant (employee) contributions | $722,810 |
| Other contributions (incl. rollovers in) | $21,210 |
| Administrative expenses paid from the plan | $30,583 |
| Contract administrator fees | $15,760 |
| Investment advisory & management fees | $14,823 |
| Benefits paid out | $168,330 |
| Net assets, start / end of year | $5.5M / $7.2M |
| Active participants, start / end of year | 515 / 537 |
| Participants with account balances | 218 |
| Auto-enrollment (feature code 2S) | Not reported |
Largest service providers (Schedule C)
| Paychex, Inc. | $15,735 reported compensation |
| Merrill Lynch, Pierce, Fenner | $14,823 reported compensation |
Source: DOL EFAST2 Form 5500 filing, acknowledgment ID 20251016153333NAL0013115298001, received 2025-10-16, EIN 01-0680942, plan #001, plan year 2024-01-01 to 2024-12-31. Verify at efast.dol.gov.